Tier 3 — preclinical
Effects of Coenzyme Q10, Tryptophan, and Magnesium Supplementation on Fatigue in Patients with Fibromyalgia - A Randomized Trial
Journal of Dietary Supplements
2025
22(3):433-444
Bibliography
- PubMed
- PMID 40151031
- Funding
- Not reported in the accessible PubMed record.
- Competing interests
- Not reported in the accessible PubMed record.
Study snapshot
| Design | Randomized, double-blind, placebo-controlled two-period crossover trial |
|---|---|
| Model | Adults with fibromyalgia |
| Sample | 110 enrolled; 89 completed; 96.6% women |
| Intervention | Combination supplement containing CoQ10, tryptophan and magnesium |
| Duration | Two 3-month treatment periods separated by a 1-month washout |
| Endpoints | ICAF fatigue item; Pain intensity; Sleep quality; Functional impact; ICAF total score; Adverse events |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
- CoQ10 for Fibromyalgia: Pain, Fatigue & What Human Studies ShowDoes CoQ10 help fibromyalgia? Review the small CoQ10 trial, 2024 systematic review and 2025 combination RCT for pain, fatigue, sleep and Fibromyalgia...Read analysis
- CoQ10 Benefits: What Human Studies Actually ShowCoQ10 benefits ranked by human evidence: heart failure, migraine, fatigue, blood pressure, metabolism, fertility, statins, exercise and where claims remain unproven.Read analysis
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified



